Grifols (GRFS) Return on Invested Capital (2011 - 2020)
Grifols' (GRFS) quarterly Return on Invested Capital came in at 0.0% in Q1 2020, little changed YoY from 0.0% in Q2 2019, and up 18.26% on a QoQ basis from 0.0% in Q4 2019.
Grifols (GRFS) Return on Invested Capital (2011 - 2020) Analysis & Trends
Grifols (GRFS) has 10 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2020.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2020, while the trailing twelve-month figure through Mar 2020 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital advanced to 0.0% in Q1 2020, from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q2 2016 to a low of 0.0% in Q1 2017.
- A 5-year average of 0.0% and a median of 0.0% in 2018 frame the typical range for Return on Invested Capital.
- The widest YoY moves for Return on Invested Capital: up 0 bps in 2016, down 2 bps in 2016.
- Tracing GRFS's Return on Invested Capital over 5 years: stood at 0.0% in 2016, then fell by 1 bps to 0.0% in 2017, then surged by 32 bps to 0.0% in 2018, then soared by 63 bps to 0.0% in 2019, then gained by 18 bps to 0.0% in 2020.
- The last three Return on Invested Capital figures came in at 0.0% (Q1 2020), 0.0% (Q4 2019), and 0.0% (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.01% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.01% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.01% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.00% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.01% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.01% |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.02% |
| Jun 30, 2016 | 0.02% |
| Dec 31, 2015 | 0.02% |
| Sep 30, 2015 | 0.02% |
| Jun 30, 2015 | 0.02% |
| Mar 31, 2015 | 32.99% |
| Jun 30, 2014 | 1.65% |
| Mar 31, 2014 | 0.01% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 0.01% |